{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:38:52Z","timestamp":1770313132875,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-026-00766-w","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:18:43Z","timestamp":1770261523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pistagremic acid from Pistacia integerrima as a natural multi-target candidate tackling crucial enzymes involved in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Muhammad","family":"Asim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Marryum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Naz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdur","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouman","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umer","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuneera","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa F.","family":"Alsanie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulhakeem S.","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal F.","family":"Alshammary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ribaudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, the International Natural Product Sciences Taskforce, Orhan IE, Banach M, Rollinger JM, Barreca D, Weckwerth W, Bauer R et al (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20:200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1057\/s41271-016-0002-7","volume":"37","author":"BX Lee","year":"2016","unstructured":"Lee BX, Kjaerulf F, Turner S, Cohen L, Donnelly PD, Muggah R, Davis R, Realini A, Kieselbach B, MacGregor LS et al (2016) Transforming our world: implementing the 2030 agenda through sustainable development goal indicators. J Public Health Pol 37:13\u201331. https:\/\/doi.org\/10.1057\/s41271-016-0002-7","journal-title":"J Public Health Pol"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"104960","DOI":"10.1016\/j.neures.2025.104960","volume":"220","author":"M Masuda-Suzukake","year":"2025","unstructured":"Masuda-Suzukake M, Shimonaka S, Nonaka T, Hasegawa M (2025) Animal models of Tau propagation in alzheimer\u2019s disease. Neurosci Res 220:104960. https:\/\/doi.org\/10.1016\/j.neures.2025.104960","journal-title":"Neurosci Res"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Sig Transduct Target Ther 9:211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Sig Transduct Target Ther"},{"key":"766_CR5","doi-asserted-by":"publisher","unstructured":"Zanforlin E, Zagotto G, Ribaudo G (2017) An overview of new possible treatments of alzheimer\u2019s Disease, based on natural products and Semi-Synthetic compounds. CMC 24. https:\/\/doi.org\/10.2174\/0929867324666170712161829","DOI":"10.2174\/0929867324666170712161829"},{"key":"766_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2025.2495856","volume-title":"Mechanistic investigation on compounds from Amorpha fruticosa L. Targeting acetylcholinesterase","author":"E Durosini","year":"2025","unstructured":"Durosini E, Anyanwu M, Vendrame T, Gianoncelli A, Ribaudo G (2025) Mechanistic investigation on compounds from Amorpha fruticosa L. Targeting acetylcholinesterase. Nat Prod Res https:\/\/doi.org\/10.1080\/14786419.2025.2495856"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cells10061309","volume":"10","author":"X Chen","year":"2021","unstructured":"Chen X, Drew J, Berney W, Lei W (2021) Neuroprotective natural products for alzheimer\u2019s disease. Cells 10:1309. https:\/\/doi.org\/10.3390\/cells10061309","journal-title":"Cells"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.3390\/ijms24108827","volume":"24","author":"SW Kim","year":"2023","unstructured":"Kim SW, Lee JH, Kim B, Yang G, Kim JU (2023) Natural products as the potential to improve alzheimer\u2019s and parkinson\u2019s disease. IJMS 24:8827. https:\/\/doi.org\/10.3390\/ijms24108827","journal-title":"IJMS"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"102572","DOI":"10.1016\/j.jksus.2023.102572","volume":"35","author":"A Rauf","year":"2023","unstructured":"Rauf A, Naz S, Muhammad N, Wadood A, Khan A, Alsahammari A, Alharbi M, Jeandet P (2023) Vitro leishmanicidal potential and Silico study of flavonoids isolated from pistacia Integerrima stew ex brandis. J King Saud Univ - Sci 35:102572. https:\/\/doi.org\/10.1016\/j.jksus.2023.102572","journal-title":"J King Saud Univ - Sci"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/ptr.6720","volume":"34","author":"R Ahmad","year":"2020","unstructured":"Ahmad R, Almubayedh H, Ahmad N, Naqvi AA, Riaz M, Ethnobotany (2020) Ethnopharmacology, Phytochemistry, biological activities and toxicity of Pistacia chinensis subsp. integerrima: A comprehensive review. Phytother Res 34:2793\u20132819. https:\/\/doi.org\/10.1002\/ptr.6720","journal-title":"Phytother Res"},{"key":"766_CR11","first-page":"1009","volume":"28","author":"Y Bibi","year":"2015","unstructured":"Bibi Y, Zia M, Qayyum A (2015) Review-An overview of pistacia Integerrima a medicinal plant species: Ethnobotany, biological activities and phytochemistry. Pak J Pharm Sci 28:1009\u20131013","journal-title":"Pak J Pharm Sci"},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jff.2019.01.007","volume":"54","author":"M Zorzan","year":"2019","unstructured":"Zorzan M, Collazuol D, Ribaudo G, Ongaro A, Scaroni C, Zagotto G, Armanini D, Barollo S, Galeotti F, Volpi N et al (2019) Biological effects and potential mechanisms of action of pistacia lentiscus Chios mastic extract in Caco-2 cell model. J Funct Foods 54:92\u201397. https:\/\/doi.org\/10.1016\/j.jff.2019.01.007","journal-title":"J Funct Foods"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1055\/a-1014-1075","volume":"85","author":"R Moeini","year":"2019","unstructured":"Moeini R, Memariani Z, Asadi F, Bozorgi M, Gorji N (2019) Pistacia genus as a potential source of neuroprotective natural products. Planta Med 85:1326\u20131350. https:\/\/doi.org\/10.1055\/a-1014-1075","journal-title":"Planta Med"},{"key":"766_CR14","doi-asserted-by":"publisher","unstructured":"Alsharif B, Biasiotti M, Bader A, Kukula-Koch W, Davey GP, Boylan F (2025) Acetylcholinesterase and monoamine oxidase inhibitory activities of Pistacia falcata Becc. Ex Martelli extract. Nat Prod Res 1\u20136. https:\/\/doi.org\/10.1080\/14786419.2025.2472272","DOI":"10.1080\/14786419.2025.2472272"},{"key":"766_CR15","doi-asserted-by":"publisher","unstructured":"Hegde SN, Begum N, Bhatt A, Kukkupuni SK, Venkatasubramanian P, Sastry JLN, Badrinarayan S, Gowda M, Narendran P (2022) De Novo genome assembly and annotation of Gall-Forming medicinal plant pistacia chinensis Subsp. Integerrima (J. L. Stewart ex Brandis) Rech. F. J Genet 101. https:\/\/doi.org\/10.1007\/s12041-022-01391-w","DOI":"10.1007\/s12041-022-01391-w"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10600-014-0875-2","volume":"50","author":"A Rauf","year":"2014","unstructured":"Rauf A, Uddin G, Latif A, Muhammad N (2014) Pistagremic Acid, a novel antimicrobial and antioxidant isolated from pistacia Integerrima. Chem Nat Compd 50:97\u201399. https:\/\/doi.org\/10.1007\/s10600-014-0875-2","journal-title":"Chem Nat Compd"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"o711","DOI":"10.1107\/S1600536811006283","volume":"67","author":"M Arfan","year":"2011","unstructured":"Arfan M, Rauf A, Tahir MN, Ali M, Uddin G (2011) 2-Methyl-6-(4,4,10,13,14-Pentamethyl-3-Oxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-Tetradecahydro-1 H -Cyclopenta[ a ]Phenanthren-17-Yl)Hept-2-Enoic acid. Acta Crystallogr E Struct Rep Online 67:o711\u2013o711. https:\/\/doi.org\/10.1107\/S1600536811006283","journal-title":"Acta Crystallogr E Struct Rep Online"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1080\/14786419.2014.997231","volume":"29","author":"A Rauf","year":"2015","unstructured":"Rauf A, Uddin G, Khan A, Siddiqui BS, Arfan M, Dalvandi K, Hadda TB (2015) Pistagremic Acid, a novel \u03b2-Secretase enzyme (BACE1) inhibitor from Pistacia Integerrima Stewart. Nat Prod Res 29:1735\u20131738. https:\/\/doi.org\/10.1080\/14786419.2014.997231","journal-title":"Nat Prod Res"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1039\/c9md00337a","volume":"10","author":"L Blaikie","year":"2019","unstructured":"Blaikie L, Kay G, Kong Thoo Lin P (2019) Current and emerging therapeutic targets of alzheimer\u2019s disease for the design of Multi-Target directed ligands. Medchemcomm 10:2052\u20132072. https:\/\/doi.org\/10.1039\/c9md00337a","journal-title":"Medchemcomm"},{"key":"766_CR20","doi-asserted-by":"publisher","unstructured":"Mathew A, Balaji E, Pai V, Kishore SRK, Pai A, Pemmireddy V (2023) R.; K.S, C. Current Drug Targets in Alzheimer\u2019s Associated Memory Impairment: AComprehensive Review. CNSNDDT 22, 255\u2013275. https:\/\/doi.org\/10.2174\/1871527321666220401124719","DOI":"10.2174\/1871527321666220401124719"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1212\/CON.0000000000001503","volume":"30","author":"DS Geldmacher","year":"2024","unstructured":"Geldmacher DS (2024) Treatment of alzheimer disease. Continuum 30:1823\u20131844. https:\/\/doi.org\/10.1212\/CON.0000000000001503","journal-title":"Continuum"},{"key":"766_CR22","first-page":"22","volume":"112","author":"EM Johnston","year":"2025","unstructured":"Johnston EM, Lounsbery JL (2025) Benzgalantamine (Zunveyl) for the treatment of mild to moderate alzheimer disease. Am Fam Physician 112:22\u201323","journal-title":"Am Fam Physician"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"112556","DOI":"10.1016\/j.biopha.2021.112556","volume":"146","author":"S Zhou","year":"2022","unstructured":"Zhou S, Huang G (2022) The biological activities of butyrylcholinesterase inhibitors. Biomed Pharmacother 146:112556. https:\/\/doi.org\/10.1016\/j.biopha.2021.112556","journal-title":"Biomed Pharmacother"},{"key":"766_CR24","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.apsb.2025.02.030","volume":"15","author":"Z Sang","year":"2025","unstructured":"Sang Z, Huang S, Tan W, Ban Y, Wang K, Fan Y, Chen H, Zhang Q, Liang C, Mi J et al (2025) Discovery of novel butyrylcholinesterase inhibitors for treating alzheimer\u2019s disease. Acta Pharm Sinica B 15:2134\u20132155. https:\/\/doi.org\/10.1016\/j.apsb.2025.02.030","journal-title":"Acta Pharm Sinica B"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00401-024-02712-2","volume":"147","author":"M Jaisa-aad","year":"2024","unstructured":"Jaisa-aad M, Mu\u00f1oz-Castro C, Healey MA, Hyman BT, Serrano-Pozo A (2024) Characterization of monoamine Oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in alzheimer\u2019s disease and related dementias. Acta Neuropathol 147:66. https:\/\/doi.org\/10.1007\/s00401-024-02712-2","journal-title":"Acta Neuropathol"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM, Bungau S, Bumbu AG (2021) Role of monoamine oxidase activity in alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules 26:3724. https:\/\/doi.org\/10.3390\/molecules26123724","journal-title":"Molecules"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/ph15121560","volume":"15","author":"SL Cheong","year":"2022","unstructured":"Cheong SL, Tiew JK, Fong YH, Leong HW, Chan YM, Chan ZL, Kong EWJ (2022) Current pharmacotherapy and Multi-Target approaches for alzheimer\u2019s disease. Pharmaceuticals 15:1560. https:\/\/doi.org\/10.3390\/ph15121560","journal-title":"Pharmaceuticals"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.3390\/molecules30142975","volume":"30","author":"A Asim","year":"2025","unstructured":"Asim A, Jastrz\u0119bski MK, Kaczor AA (2025) Dual inhibitors of acetylcholinesterase and monoamine Oxidase-B for the treatment of alzheimer\u2019s disease. Molecules 30:2975. https:\/\/doi.org\/10.3390\/molecules30142975","journal-title":"Molecules"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2174\/1567205018666211208140551","volume":"18","author":"R Bhatia","year":"2021","unstructured":"Bhatia R, Chakrabarti SS, Kaur U, Parashar G, Banerjee A, Rawal RK (2021) Multi-Target directed ligands (MTDLs): promising coumarin hybrids for alzheimer\u2019s disease. CAR 18:802\u2013830. https:\/\/doi.org\/10.2174\/1567205018666211208140551","journal-title":"CAR"},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/ph15101202","volume":"15","author":"HAS El-Nashar","year":"2022","unstructured":"El-Nashar HAS, Abbas H, Zewail M, Noureldin MH, Ali MM, Shamaa MM, Khattab MA, Ibrahim N (2022) Neuroprotective effect of Artichoke-Based nanoformulation in sporadic alzheimer\u2019s disease mouse model: focus on Antioxidant, Anti-Inflammatory, and amyloidogenic pathways. Pharmaceuticals 15:1202. https:\/\/doi.org\/10.3390\/ph15101202","journal-title":"Pharmaceuticals"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.53388\/TMR20241203001","volume":"10","author":"A Rauf","year":"2025","unstructured":"Rauf A, Khan MU, Akram Z, Shabbir CA, Al-Awthan YS, Bahattab OS, Mujawah AAH, Hemeg HA, Iriti M (2025) Lipoxygenase inhibitory potential of secondary metabolites isolated from pistacia integerrima: A comprehensive in vitro analysis integrating molecular Docking, ADMET and DFT studies. Tradit Med Res 10:52. https:\/\/doi.org\/10.53388\/TMR20241203001","journal-title":"Tradit Med Res"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.phytol.2024.09.001","volume":"64","author":"A Rauf","year":"2024","unstructured":"Rauf A, Khan M, Nizamani A, Hussain H, Akram Z, Al-Awthan YS, Hemeg HA, Bahattab OS, Ribaudo G (2024) Multi-Target anticancer activity of compounds isolated from galls of pistacia chinensis Subsp. Integerrima: A mechanistic investigation. Phytochem Lett 64:6\u201312. https:\/\/doi.org\/10.1016\/j.phytol.2024.09.001","journal-title":"Phytochem Lett"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18332\/pht\/172229","volume":"3","author":"AB Patel","year":"2023","unstructured":"Patel AB (2023) Simple and rapid colorimetric method for determination of erythrocyte and plasma cholinesterase activities and comparison with the standard ellman\u2019s method. Public Health Toxicol 3:1\u201310. https:\/\/doi.org\/10.18332\/pht\/172229","journal-title":"Public Health Toxicol"},{"key":"766_CR35","doi-asserted-by":"publisher","first-page":"114239","DOI":"10.1016\/j.biopha.2023.114239","volume":"159","author":"MA Javed","year":"2023","unstructured":"Javed MA, Jan MS, Shbeer AM, Al-Ghorbani M, Rauf A, Wilairatana P, Mannan A, Sadiq A, Farooq U, Rashid U (2023) Evaluation of Pyrimidine\/Pyrrolidine-Sertraline based hybrids as multitarget Anti-Alzheimer agents: In-Vitro, in-Vivo, and computational studies. Biomed Pharmacother 159:114239. https:\/\/doi.org\/10.1016\/j.biopha.2023.114239","journal-title":"Biomed Pharmacother"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"128994","DOI":"10.1016\/j.bmcl.2022.128994","volume":"76","author":"R Jadoon","year":"2022","unstructured":"Jadoon R, Aamir Javed M, Saeed Jan M, Ikram M, Mahnashi MH, Sadiq A, Shahid M, Rashid U, Design (2022) Synthesis, in-Vitro, in-Vivo and Ex-Vivo Pharmacology of Thiazolidine-2,4-Dione derivatives as selective and reversible monoamine Oxidase-B inhibitors. Bioorg Med Chem Lett 76:128994. https:\/\/doi.org\/10.1016\/j.bmcl.2022.128994","journal-title":"Bioorg Med Chem Lett"},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1021\/jm060164b","volume":"49","author":"EH Rydberg","year":"2006","unstructured":"Rydberg EH, Brumshtein B, Greenblatt HM, Wong DM, Shaya D, Williams LD, Carlier PR, Pang Y-P, Silman I, Sussman JL (2006) Complexes of Alkylene-Linked Tacrine dimers with Torpedo c Alifornica acetylcholinesterase: binding of Bis(5)-Tacrine produces a dramatic rearrangement in the Active-Site gorge. J Med Chem 49:5491\u20135500. https:\/\/doi.org\/10.1021\/jm060164b","journal-title":"J Med Chem"},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, Renard P-Y (2013) Crystal structures of human cholinesterases in complex with Huprine W and tacrine: elements of specificity for Anti-Alzheimer\u2019s drugs targeting Acetyl- and Butyryl-Cholinesterase. Biochem J 453:393\u2013399. https:\/\/doi.org\/10.1042\/BJ20130013","journal-title":"Biochem J"},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs. J Med Chem 50:5848\u20135852. https:\/\/doi.org\/10.1021\/jm070677y","journal-title":"J Med Chem"},{"key":"766_CR40","doi-asserted-by":"publisher","first-page":"10304","DOI":"10.1039\/D4RA00766B","volume":"14","author":"F Hussain","year":"2024","unstructured":"Hussain F, Tahir A, Jan MS, Fatima N, Sadiq A, Rashid U (2024) Exploitation of the multitarget role of new ferulic and Gallic acid derivatives in oxidative Stress-Related alzheimer\u2019s disease therapies: Design, synthesis and bioevaluation. RSC Adv 14:10304\u201310321. https:\/\/doi.org\/10.1039\/D4RA00766B","journal-title":"RSC Adv"},{"key":"766_CR41","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera?A visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V, SwissTargetPrediction (2019) Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Res"},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285","journal-title":"J Nat Prod"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/ph14010058","volume":"14","author":"G Ribaudo","year":"2021","unstructured":"Ribaudo G, Memo M, Gianoncelli AA (2021) Perspective on natural and Nature-Inspired small molecules targeting phosphodiesterase 9 (PDE9): chances and challenges against neurodegeneration. Pharmaceuticals 14:58. https:\/\/doi.org\/10.3390\/ph14010058","journal-title":"Pharmaceuticals"},{"key":"766_CR45","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.3390\/app11115044","volume":"11","author":"G Ribaudo","year":"2021","unstructured":"Ribaudo G, Memo M, Gianoncelli A (2021) Multi-Target natural and Nature-Inspired compounds against neurodegeneration: A focus on dual cholinesterase and phosphodiesterase inhibitors. Appl Sci 11:5044. https:\/\/doi.org\/10.3390\/app11115044","journal-title":"Appl Sci"},{"key":"766_CR46","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.3390\/molecules25184312","volume":"25","author":"BN Sa\u011fl\u0131k","year":"2020","unstructured":"Sa\u011fl\u0131k BN, Osmaniye D, Acar \u00c7evik U, Levent S, Kaya \u00c7avu\u015fo\u011flu B, \u00d6zkay Y, Kaplanc\u0131kl\u0131 ZA, Design (2020) Synthesis, and Structure\u2013Activity relationships of thiazole analogs as anticholinesterase agents for alzheimer\u2019s disease. Molecules 25:4312. https:\/\/doi.org\/10.3390\/molecules25184312","journal-title":"Molecules"},{"key":"766_CR47","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2174\/092986609789071207","volume":"16","author":"P Masson","year":"2009","unstructured":"Masson P, Carletti E, Nachon F (2009) Structure, activities and biomedical applications of human butyrylcholinesterase. PPL 16:1215\u20131224. https:\/\/doi.org\/10.2174\/092986609789071207","journal-title":"PPL"},{"key":"766_CR48","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1021\/bi980536l","volume":"37","author":"F Nachon","year":"1998","unstructured":"Nachon F, Ehret-Sabatier L, Loew D, Colas C, Van Dorsselaer A, Goeldner M (1998) Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3 H]DDF. Biochemistry 37:10507\u201310513. https:\/\/doi.org\/10.1021\/bi980536l","journal-title":"Biochemistry"},{"key":"766_CR49","doi-asserted-by":"publisher","first-page":"117995","DOI":"10.1016\/j.biopha.2025.117995","volume":"186","author":"D Ku\u0142aga","year":"2025","unstructured":"Ku\u0142aga D, Drabczyk AK, Zar\u0119ba P, Ja\u015bkowska J, Sata\u0142a G, Zar\u0119ba P, Wi\u0119ckowska A, De Candia M, Purgatorio R, Boguszewska-Czubara A et al (2025) Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat alzheimer\u2019s disease symptoms. Biomed Pharmacother 186:117995. https:\/\/doi.org\/10.1016\/j.biopha.2025.117995","journal-title":"Biomed Pharmacother"},{"key":"766_CR50","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s00894-012-1390-7","volume":"18","author":"FP Moraes","year":"2012","unstructured":"Moraes FP, De Azevedo WF (2012) Targeting Imidazoline site on monoamine oxidase B through molecular Docking simulations. J Mol Model 18:3877\u20133886. https:\/\/doi.org\/10.1007\/s00894-012-1390-7","journal-title":"J Mol Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00766-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00766-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00766-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:18:44Z","timestamp":1770261524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00766-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00766-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"59"}}